Strazeneca Covid-19 Vaccine And Covishield: Risk Of Capillary Leak Syndrome
COVID-19 Vaccine Recall Summary AstraZeneca's COVID-19 vaccine and COVISHIELD have been recalled across Canada due to a risk of capillary leak syndrome, a condition where fluid leaks from small blood vessels into surrounding tissues. This recall affects all doses of these vaccines that were distributed throughout Canada. The recall was initiated based on product safety concerns related to this potential adverse effect.
- Reason
- COVID - Product safety
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2021-06-29
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/216c7e65-9c35-44a6-98fb-ec62654d93ae